Joyonna Gamble-George, MHA, PhD

With over a decade of experience discovering cures for the most common health diseases and disorders, Dr. Joyonna Gamble-George is an internationally acclaimed scientist and Research Faculty in the Department of Social and Behavioral Sciences at Yale School of Public Health. She has traveled the globe sharing her research approaches to medicine with diverse audiences, including Nobel Prize winners.

Previously, Dr. Gamble-George worked as a subject matter expert for the National Institutes of Health, where she was an advisor for doctors, psychologists, nurses, and other scientists across the United States that conduct research on chronic heart and lung diseases and mental health in people living with HIV. She was also an All of Us Biomedical Researcher Scholar at Baylor College of Medicine, where she used Python and R programming to evaluate opioid misuse and heart failure prevalence and genetic risk factors involved in inflammation in systemic lupus erythematosus (SLE) patients from the NIH All of Us Research Program. Dr. Gamble-George studied at New York University how interactions between an individual’s genes and their social environment contribute to mental health problems and other health risk behaviors in adolescents and adults using brain imaging and behavioral science methods.

Dr. Gamble-George received over 20 awards for her leadership, philanthropy, and dedication to science while fostering diversity. Given her considerable accomplishments, she was selected for the AAAS IF/THEN Ambassador program, which brings together women in different STEM careers to serve as high-profile role models for middle school girls. She recently received the National Institutes of Health Director's Award for her dedication and advancement of women's health research, workforce development, and health education.

Dr. Gamble-George holds a Bachelor of Science in Biochemistry and Biology with Honors in Mathematics from Xavier University of Louisiana, a Master of Health Administration from the University of South Florida College of Public Health, and a Doctor of Philosophy in Neuroscience from Vanderbilt University. She completed postdoctoral training at the University of Florida, where her research focused on illicit drug effects on cell-cell communication in the human brain and animal models of HIV-1 infection.